Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Ready
Primary summary from verified readiness
- Confidence
- 86% · stale
- Computed at
- 2026-09-30T20:55:21.42369+00:00
- Claimed
- 55
- Reported
- 55
- Verified
- 55
- Gap
- 0
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed and verified align
Evidence strength Strong
Decision
What the current evidence supports
Agent-assisted assessment · independently reviewed · 2026-09-30
An approved treatment option for adult dermatomyositis in the US.
- Why
- A randomized trial and FDA review support clinical benefit, with significant safety precautions and limited post-launch experience.
- Next
- Evaluate use through specialist care under the approved label, and follow postmarketing safety and effectiveness evidence.
Constraints
Blockers
- Boxed warnings and required clinical safety monitoring
- Limited long-term postmarketing evidence
- Specialty-pharmacy distribution and insurance access
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 8
- Tier 1
- 4
- Tier 2
- 4
- Tier 3
- 0
- Supports
- 7
- Contradicts
- 1
- Context
- 0
- Latest observed
- 2026-08-28
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Revision 3
- 2026-09-21 Reading moved from mature to mature.
- 2026-09-22 Reading moved from mature to mature.
- 2026-09-30 Reading moved from mature to ready.